- Merrimack Pharmaceuticals (NASDAQ:MACK): Q4 EPS of -$0.09 beats by $0.10.
- Revenue of $33.9M (+333.5% Y/Y) beats by $5.12M.
- Press Release
Merrimack Pharmaceuticals beats by $0.10, beats on revenue
Recommended For You
About MACK Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| MACK | - | - |
| Merrimack Pharmaceuticals, Inc. | ||